RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
:)
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
RT @Crit_Care: https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FO…
https://t.co/420fS0Krdp A slower progression to death associated with #atorvastatin in patients with #COVID_19 #FOAMed #FOAMcc #BMC #ICU #COVID_19 #infection #coronavirus #epidemics @jlvincen @ISICEM https://t.co/ziWrthS5x3
RT @Infermiere_line: Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an #ICU: a retrospective coho…
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an #ICU: a retrospective cohort study @Crit_Care | #ECM https://t.co/JRfiO0kNx4
アトルバスタチンとCOVID-19のICU入院患者における死亡ハザードの減少との関連:レトロスペクティブコホート研究 合計24人(61.5%)の生存者がアトルバスタチン40mgを1日に投与されていたのに対し、非生存者では23人(47.9%)であった https://t.co/PgUgUIU1Wn